Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.25 for the 2020 fiscal year.


Weaknesses

● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The company does not generate enough profits, which is an alarming weak point.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 404.45 times its estimated earnings per share for the ongoing year.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.